ATYPICAL AUTOANTIGEN TARGETS OF PERINUCLEAR ANTINEUTROPHIL CYTOPLASM ANTIBODIES (P-ANCA) - SPECIFICITY AND CLINICAL ASSOCIATIONS

被引:37
|
作者
LESAVRE, P
NOEL, LH
GAYNO, S
NUSBAUM, P
REUMAUX, D
ERLINGER, S
GRUNFELD, JP
HALBWACHSMECARELLI, L
机构
[1] HOP BEAUJON, DEPT HEPATOL & GASTROENTEROL, F-92118 CLICHY, FRANCE
[2] HOP NECKER ENFANTS MALAD, INSERM, U90, F-75743 PARIS 15, FRANCE
[3] HOP BEAUJON, INSERM, U24, F-92118 CLICHY, FRANCE
[4] CTR HOSP VALENCIENNES, DEPT BIOL, F-59322 VALENCIENNES, FRANCE
关键词
D O I
10.1006/jaut.1993.1016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Atypical antineutrophil cytoplasm antibodies (A-ANCA) are defined here as ANCA detected by IIF and not directed against the predominant ANCA antigens, proteinase 3 (PR3) and myeloperoxidase (MPO). A-ANCA are found in a variety of clinical conditions, namely rheumatoid arthritis, inflammatory bowel diseases, chronic hepatic diseases and several infections including HIV infection. They are directed against a variety of still ill-defined neutrophil antigens and most frequently yield a perinuclear pattern (P-ANCA) of binding by indirect immunofluorescence on ethanol fixed neutrophils. This paper reviews the literature on A-ANCA and our recent data suggesting that, among others, cathepsin G is one of the predominant antigen targets of A-ANCA. From a clinical point of view, the distinction between MPO-ANCA and A-ANCA is not possible by indirect immunofluorescence (IIF). The determination of ANCA antigens by specific ELISA is therefore necessary to differentiate P-ANCA with MPO specificity from those with undefined specificity. This is of importance because the clinical value of MPO-ANCA is clearly established while the presence of A-ANCA is difficult to interpret given their occurrence in a large variety of clinical conditions. © 1993 Academic Press Limited.
引用
收藏
页码:185 / 195
页数:11
相关论文
共 32 条
  • [31] Diagnostic role and clinical correlates of anti-Saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases
    Saibeni, S
    Folli, C
    de Franchis, R
    Borsi, G
    Vecchi, M
    DIGESTIVE AND LIVER DISEASE, 2003, 35 (12) : 862 - 868
  • [32] Phenotypic Associations of Crohn's Disease with Antibodies to Flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 Mutations in a Swiss Cohort
    Schoepfer, Alain M.
    Schaffer, Thomas
    Mueller, Stefan
    Flogerzi, Beatrice
    Vassella, Erik
    Seibold-Schmid, Beatrice
    Seibold, Frank
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (09) : 1358 - 1367